Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Stereotaxis

Stereotaxis
1990 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
STXS STOCK SYMBOL
$2.06 SHARE PRICE (As of Friday Closing)
Description

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the company platform. The core components of its systems have received regulatory clearance including United States, European Union, Japan, Canada, and China.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
PINX
Primary Office
  • 4320 Forest Park Avenue
  • Suite 100
  • Saint Louis, MO 63108
  • United States

+1 (314) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Stereotaxis’s full profile, request a free trial.

Stereotaxis Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.51 - $2.45 $129M $2.18 -$0.03 62.4K 59.2M

Stereotaxis Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 58,226 58,226 46,490 45,176
Revenue 29,347 29,347 31,144 32,164
EBITDA 712 712 (4,954) (2,236)
Net Income 117 117 (5,887) (5,287)
Total Assets 18,515 18,515 10,667 20,966
Total Debt 0 0 19,575 19,787
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Stereotaxis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Stereotaxis‘s full profile, request access.

Request full access to PitchBook

Stereotaxis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Stereotaxis‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Stereotaxis Executive Team (6)

Name Title Board
Seat
Contact
Info
Michael Kaminski Chief Executive Officer
Martin Stammer Chief Financial Officer
Samuel Duggan II Chief Financial Officer
Richard Pettibone Senior Director, Operations

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Stereotaxis Board Members (10)

Name Representing Role Since Contact
Info
David Benfer Self Board Member 000 0000
Eric Prystowsky MD Self Board Member 000 0000
Euan Thomson Ph.D Stereotaxis Board Director 000 0000
Joseph Keegan Ph.D Self Board Member 000 0000
Robert Messey Self Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »